Safety and Efficacy of Pletal(Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud's Phenomenon
- Conditions
- Raynaud's Disease
- Registration Number
- NCT00048763
- Lead Sponsor
- Otsuka America Pharmaceutical
- Brief Summary
Juvenile primary Raynaud's (ray-knows) Phenomenon is a disorder of the blood vessels in the fingers and sometimes can affect the toes, nose, or ears. When children with primary Raynaud's Phenomenon are exposed to chilly or cold conditions from weather, cold temperatures, or even holding cold items from the refrigerator, their fingers may become cold, numb, hurt, and/or turn purple or white. Children with primary Raynaud's Phenomenon have no underlying systemic disease. The cause for their symptoms is unknown. The investigational drug, Pletal(cilostazol), which has been approved for other conditions, inhibits the ability of one type of blood cell, platelets, to form blood clots, and also widens narrowed blood vessels. It has been used in a variety of other conditions in which blood flow is decreased. This study will test the safety and effectiveness Pletal(cilostazol) to lessen the severity of the symptoms and decrease the number of primary Raynaud's episodes in juvenile patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 75
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (18)
Advanced Medical Clinical Therapeutics
๐บ๐ธAnchorage, Alaska, United States
Advanced Medical Research Institute
๐บ๐ธFresno, California, United States
Madera Family Medical Group
๐บ๐ธMadera, California, United States
Connecticut Children's Medical Center
๐บ๐ธHartford, Connecticut, United States
LaRabida Children's Hospital
๐บ๐ธChicago, Illinois, United States
Children's Hospital Boston
๐บ๐ธBoston, Massachusetts, United States
St. Louis University Health Sciences Center
๐บ๐ธSt. Louis, Missouri, United States
Children's Hospital
๐บ๐ธOmaha, Nebraska, United States
Asthma & Allergy Research Center
๐บ๐ธNewark, New Jersey, United States
SUNY Downstate Medical Center
๐บ๐ธBrooklyn, New York, United States
Scroll for more (8 remaining)Advanced Medical Clinical Therapeutics๐บ๐ธAnchorage, Alaska, United States